Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2025381191-A1 · Dec 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Hendriks Bart S patents
Hendriks Bart S is listed as an inventor on 25 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hendriks Bart S |
| Total patents | 25 |
| First publication | Apr 23, 2015 |
| Latest publication | Dec 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2024358706-A1 · Oct 31, 2024 · US
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2023062425-A1 · Mar 2, 2023 · US
Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
US-11344552-B2 · May 31, 2022 · US
Compositions and methods for non-invasive imaging
US-9968694-B2 · May 15, 2018 · US
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2018078556-A1 · Mar 22, 2018 · US
Combination therapy for treating HER2-positive cancers
US-9913901-B2 · Mar 13, 2018 · US
Combination therapies for treating her2-positive cancers that are resistant to her2-targeted therapies
US-2017258903-A1 · Sep 14, 2017 · US
Methods and compositions for improving outcomes of liposomal chemotherapy
US-2017231911-A1 · Aug 17, 2017 · US
Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-2017189335-A1 · Jul 6, 2017 · US
Recent patents
Latest publications not already listed above.
Compositions and Methods for Non-Invasive Imaging
US-2017112950-A1 · Apr 27, 2017 · US
Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-9610249-B2 · Apr 4, 2017 · US
Marker quantitation in single cells in tissue sections
US-2017082630-A1 · Mar 23, 2017 · US
Combination Therapies for Treating Her2-Positive Cancers that are Resistant to Her2-Targeted Therapies
US-2017080087-A1 · Mar 23, 2017 · US
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2017049775-A1 · Feb 23, 2017 · US
Combination therapies for treating her2-positive cancers
US-2017022290-A1 · Jan 26, 2017 · US
Compositions and methods for non-invasive imaging
US-9511155-B2 · Dec 6, 2016 · US
Liposomes useful for non-invasive imaging and drug delivery
US-2016303264-A1 · Oct 20, 2016 · US
Combination therapy for treating her2-positive cancers
US-2016250328-A1 · Sep 1, 2016 · US
Methods and compositions for improving outcomes of liposomal chemotherapy
US-2016184227-A1 · Jun 30, 2016 · US
Methods and compositions for improving outcomes of liposomal chemotherapy
US-2016067182-A1 · Mar 10, 2016 · US
Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-2016038416-A1 · Feb 11, 2016 · US
Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-2016038417-A1 · Feb 11, 2016 · US
Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-9226966-B2 · Jan 5, 2016 · US
Marker quantitation in single cells in tissue sections
US-2015111217-A1 · Apr 23, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merrimack Pharmaceuticals Inc | 21 |
| Ipsen Biopharm Ltd | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K9/127 | 20 |
| A61K9/0019 | 20 |
| A61K9/1271 | 20 |
| A61K31/704 | 17 |
| A61P35/00 | 14 |